Bevan CL - Search Results

1

Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on.

Estébanez-Perpiñá E, Bevan CL, McEwan IJ. Estébanez-Perpiñá E, et al. Among authors: bevan cl. Cancers (Basel). 2021 Jan 29;13(3):509. doi: 10.3390/cancers13030509. Cancers (Basel). 2021. PMID: 33572755 Free PMC article. Review.

2

Allosteric conversation in the androgen receptor ligand-binding domain surfaces.

Grosdidier S, Carbó LR, Buzón V, Brooke G, Nguyen P, Baxter JD, Bevan C, Webb P, Estébanez-Perpiñá E, Fernández-Recio J. Grosdidier S, et al. Mol Endocrinol. 2012 Jul;26(7):1078-90. doi: 10.1210/me.2011-1281. Epub 2012 May 31. Mol Endocrinol. 2012. PMID: 22653923 Free PMC article.

3

Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?

Orafidiya F, Deng L, Bevan CL, Fletcher CE. Orafidiya F, et al. Among authors: bevan cl. Cancers (Basel). 2022 Jan 31;14(3):755. doi: 10.3390/cancers14030755. Cancers (Basel). 2022. PMID: 35159022 Free PMC article. Review.

4

Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy.

Buxton AK, Abbasova S, Bevan CL, Leach DA. Buxton AK, et al. Among authors: bevan cl. Cancers (Basel). 2022 Dec 15;14(24):6189. doi: 10.3390/cancers14246189. Cancers (Basel). 2022. PMID: 36551674 Free PMC article. Review.

5

Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate.

Powell SM, Christiaens V, Voulgaraki D, Waxman J, Claessens F, Bevan CL. Powell SM, et al. Among authors: bevan cl. Endocr Relat Cancer. 2004 Mar;11(1):117-30. doi: 10.1677/erc.0.0110117. Endocr Relat Cancer. 2004. PMID: 15027889

6

Androgen receptor in prostate cancer: cause or cure?

Bevan CL. Bevan CL. Trends Endocrinol Metab. 2005 Nov;16(9):395-7. doi: 10.1016/j.tem.2005.09.006. Epub 2005 Oct 3. Trends Endocrinol Metab. 2005. PMID: 16202619

7

Mechanisms of androgen receptor repression in prostate cancer.

Powell SM, Brooke GN, Whitaker HC, Reebye V, Gamble SC, Chotai D, Dart DA, Belandia B, Bevan CL. Powell SM, et al. Among authors: bevan cl. Biochem Soc Trans. 2006 Dec;34(Pt 6):1124-7. doi: 10.1042/BST0341124. Biochem Soc Trans. 2006. PMID: 17073766 Free article.

8

The role of androgen receptor mutations in prostate cancer progression.

Brooke GN, Bevan CL. Brooke GN, et al. Among authors: bevan cl. Curr Genomics. 2009 Mar;10(1):18-25. doi: 10.2174/138920209787581307. Curr Genomics. 2009. PMID: 19721807 Free PMC article.

9

Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.

Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, Bevan CL. Fletcher CE, et al. Among authors: bevan cl. Hum Mol Genet. 2012 Jul 15;21(14):3112-27. doi: 10.1093/hmg/dds139. Epub 2012 Apr 14. Hum Mol Genet. 2012. PMID: 22505583 Free article.

10

Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.

Reebye V, Querol Cano L, Lavery DN, Brooke GN, Powell SM, Chotai D, Walker MM, Whitaker HC, Wait R, Hurst HC, Bevan CL. Reebye V, et al. Among authors: bevan cl. Mol Endocrinol. 2012 Oct;26(10):1694-706. doi: 10.1210/me.2012-1056. Epub 2012 Aug 16. Mol Endocrinol. 2012. PMID: 22899854 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters